Cargando…

经皮冷冻治疗644例肺癌的常见并发症分析及处理

BACKGROUND AND OBJECTIVE: Most lung cancer patients present an advanced stage at diagnosis without suitable surgical chances. Cryotherapy has been applied to the advanced lung cancer with safety and effectiveness. The aim of this study is to analyze the most common complications that occur after per...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000546/
https://www.ncbi.nlm.nih.gov/pubmed/20704828
http://dx.doi.org/10.3779/j.issn.1009-3419.2010.08.16
_version_ 1783331763392610304
collection PubMed
description BACKGROUND AND OBJECTIVE: Most lung cancer patients present an advanced stage at diagnosis without suitable surgical chances. Cryotherapy has been applied to the advanced lung cancer with safety and effectiveness. The aim of this study is to analyze the most common complications that occur after percutaneous cryoablation when applied to advanced lung cancer. METHODS: Total 644 lung cancer patients had been treated with percutaneous cryoablation guided by ultrasound and/or CT scan. The cardivascular and respiratory complications were monitored. RESULTS: Complications were relatively minor and could be controlled with routine methods. Serious complications included cardiac arrest and hemopneumothorax, and thus preventative steps should be taken. CONCLUSION: Percutaneous cryoablation for lung cancer is a simple, effective and relatively safe method, but attention should be paid to the possible complications during cryoablation.
format Online
Article
Text
id pubmed-6000546
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-60005462018-07-06 经皮冷冻治疗644例肺癌的常见并发症分析及处理 Zhongguo Fei Ai Za Zhi 短篇报道 BACKGROUND AND OBJECTIVE: Most lung cancer patients present an advanced stage at diagnosis without suitable surgical chances. Cryotherapy has been applied to the advanced lung cancer with safety and effectiveness. The aim of this study is to analyze the most common complications that occur after percutaneous cryoablation when applied to advanced lung cancer. METHODS: Total 644 lung cancer patients had been treated with percutaneous cryoablation guided by ultrasound and/or CT scan. The cardivascular and respiratory complications were monitored. RESULTS: Complications were relatively minor and could be controlled with routine methods. Serious complications included cardiac arrest and hemopneumothorax, and thus preventative steps should be taken. CONCLUSION: Percutaneous cryoablation for lung cancer is a simple, effective and relatively safe method, but attention should be paid to the possible complications during cryoablation. 中国肺癌杂志编辑部 2010-08-20 /pmc/articles/PMC6000546/ /pubmed/20704828 http://dx.doi.org/10.3779/j.issn.1009-3419.2010.08.16 Text en 版权所有©《中国肺癌杂志》编辑部2010 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 短篇报道
经皮冷冻治疗644例肺癌的常见并发症分析及处理
title 经皮冷冻治疗644例肺癌的常见并发症分析及处理
title_full 经皮冷冻治疗644例肺癌的常见并发症分析及处理
title_fullStr 经皮冷冻治疗644例肺癌的常见并发症分析及处理
title_full_unstemmed 经皮冷冻治疗644例肺癌的常见并发症分析及处理
title_short 经皮冷冻治疗644例肺癌的常见并发症分析及处理
title_sort 经皮冷冻治疗644例肺癌的常见并发症分析及处理
topic 短篇报道
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000546/
https://www.ncbi.nlm.nih.gov/pubmed/20704828
http://dx.doi.org/10.3779/j.issn.1009-3419.2010.08.16
work_keys_str_mv AT jīngpílěngdòngzhìliáo644lìfèiáidechángjiànbìngfāzhèngfēnxījíchùlǐ
AT jīngpílěngdòngzhìliáo644lìfèiáidechángjiànbìngfāzhèngfēnxījíchùlǐ
AT jīngpílěngdòngzhìliáo644lìfèiáidechángjiànbìngfāzhèngfēnxījíchùlǐ
AT jīngpílěngdòngzhìliáo644lìfèiáidechángjiànbìngfāzhèngfēnxījíchùlǐ
AT jīngpílěngdòngzhìliáo644lìfèiáidechángjiànbìngfāzhèngfēnxījíchùlǐ
AT jīngpílěngdòngzhìliáo644lìfèiáidechángjiànbìngfāzhèngfēnxījíchùlǐ
AT jīngpílěngdòngzhìliáo644lìfèiáidechángjiànbìngfāzhèngfēnxījíchùlǐ
AT jīngpílěngdòngzhìliáo644lìfèiáidechángjiànbìngfāzhèngfēnxījíchùlǐ
AT jīngpílěngdòngzhìliáo644lìfèiáidechángjiànbìngfāzhèngfēnxījíchùlǐ
AT jīngpílěngdòngzhìliáo644lìfèiáidechángjiànbìngfāzhèngfēnxījíchùlǐ